Madrigal Pharmaceuticals, Inc.
2019 Q4 - 2025 Q4 (25 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).
| All 13F Holders | Filing date | Value ($000s) | % of Holdings | Shares | Reporting period |
|---|---|---|---|---|---|
| 2025 Q4 | 2/10/2026 | 7,046 | 0.1% | 12,100 | 12/31/2025 |
| 2025 Q3 | 10/31/2025 | 5,586 | 0.1% | 12,179 | 9/30/2025 |
| 2025 Q2 | 7/29/2025 | 3,725 | 0.0% | 12,309 | 6/30/2025 |
| 2025 Q1 | 5/9/2025 | 3,731 | 0.0% | 11,263 | 3/31/2025 |
| 2024 Q4 | 2/5/2025 | 3,466 | 0.0% | 11,232 | 12/31/2024 |
| 2024 Q3 | 11/6/2024 | 2,386 | 0.0% | 11,242 | 9/30/2024 |
| 2024 Q2 | 8/9/2024 | 3,179 | 0.0% | 11,348 | 6/30/2024 |
| 2024 Q1 | 5/2/2024 | 3,161 | 0.0% | 11,839 | 3/31/2024 |
| 2023 Q4 | 1/26/2024 | 2,962 | 0.0% | 12,803 | 12/31/2023 |
| 2023 Q3 | 11/9/2023 | 1,953 | 0.0% | 13,375 | 9/30/2023 |
| 2023 Q2 | 8/11/2023 | 3,274 | 0.0% | 14,171 | 6/30/2023 |
| 2023 Q1 | 5/4/2023 | 3,695 | 0.0% | 15,253 | 3/31/2023 |
| 2022 Q4 | 2/10/2023 | 4,631 | 0.1% | 15,954 | 12/31/2022 |
| 2022 Q3 | 11/8/2022 | 1,023 | 0.0% | 15,739 | 9/30/2022 |
| 2022 Q2 | 8/10/2022 | 1,229 | 0.0% | 17,169 | 6/30/2022 |
| 2022 Q1 | 5/2/2022 | 1,697 | 0.0% | 17,298 | 3/31/2022 |
| 2021 Q4 | 2/3/2022 | 1,530 | 0.0% | 18,050 | 12/31/2021 |
| 2021 Q3 | 11/10/2021 | 1,454 | 0.0% | 18,219 | 9/30/2021 |
| 2021 Q2 | 8/6/2021 | 1,800 | 0.0% | 18,483 | 6/30/2021 |
| 2021 Q1 | 5/13/2021 | 2,255 | 0.0% | 19,277 | 3/31/2021 |
| 2020 Q4 | 2/12/2021 | 2,262 | 0.0% | 20,343 | 12/31/2020 |
| 2020 Q3 | 11/13/2020 | 2,080 | 0.0% | 17,522 | 9/30/2020 |
| 2020 Q2 | 8/6/2020 | 2,325 | 0.0% | 20,531 | 6/30/2020 |
| 2020 Q1 | 5/11/2020 | 1,411 | 0.0% | 21,141 | 3/31/2020 |
| 2019 Q4 | 2/11/2020 | 2,011 | 0.0% | 22,071 | 12/31/2019 |